US EditionBiotech in Bavaria: Record Investments and Stable Development
Summary by bionity.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
The new BioM Annual Report "Biotech in Bavaria 2024/25 – One World for Innovation" shows: Bavaria's biopharmaceutical industry has reached a new record with over €910 million in financing – almost double the previous year's figure. The number of companies increased slightly to 540, with 18 new startups and...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
